CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETH

Delivery order SPEZD-26-F-3237, issued on August 10, 2026, under the base contract SPE2DX-25-D-9822, authorizes DMS Pharmaceutical Group Inc. to provide Ciprofloxacin Hydrochloride and Dexamethasone to the Defense Logistics Agency. The award is valued at $446.50 for the delivery of 10 bottles at a unit price of $44.65. This procurement is designated for the USS Theodore Roosevelt CVN 71, with delivery terms set as FOB Destination. The awardee is a Women-Owned Small Business operating under NAICS code 325412. The contract requires strict adherence to shipping and labeling standards, including the use of the Vendor Shipment Module and the prohibition of parcel post. All shipments must be sent via the fastest traceable means and include specific identifiers such as the manufacturer CAGE code and Bill of Lading number. Inspection and acceptance are conducted by the government at the destination. This order is governed by the Defense Priorities and Allocations System under 15 CFR 700 and incorporates various Federal Acquisition Regulation and DLA-specific procurement notes. Administrative oversight is managed by the DLA Troop Support Medical Supply Chain, with payments processed through the Defense Finance and Accounting Service.